EEDQ


CAS No. : 16357-59-8

(Synonyms: EEDQ)

16357-59-8
Price and Availability of CAS No. : 16357-59-8
Size Price Stock
25g $11 In-stock
100g $34 In-stock
250g $58 In-stock
500g $108 In-stock
1000g $178 In-stock
> 2 kg Get quote
We match the lowest price on market.

We offer a substantial discount on larger orders, please inquire via [email protected]

or Fax: (86)21-58955996

Inquiry for price and availability only. Please place your order via our email or fax.

Cat. No. : HY-Y1191
M.Wt: 247.29
Formula: C14H17NO3
Purity: >98 %
Solubility: DMSO : ≥ 100 mg/mL
Introduction of 16357-59-8 :

EEDQ is a carboxylate activator and irreversible antagonist of 5HT2c receptors. EEDQ reduces [3H]β-CIT binding to the dopamine transporter (DAT) in rat caudate-putamen (CPu) homogenates (IC50 = 78.3 μM). EEDQ inhibits contralateral rotation behavior[1][2][3][4][5]. In Vitro:EEDQ (1 mM; 30 min) has no effect on glycogen phosphorylase activity or cell viability of hepatocytes[1].
EEDQ (10-300 μM) concentration-dependently decreases [3H]β-CIT binding to dopamine transporters (DAT) in rat caudate-putamen (CPu) homogenates (IC50 = 78.3 μM)[3].
In Vivo:EEDQ (25-50 mg/kg; i.p.) dose-dependently inhibits Apomorphine (HY-12723), SKF 38393 (HY-12520A), and Quinpirole (HY-B1752)-induced contralateral rotational behavior in mice with unilateral striatal 6-hydroxydopamine lesions, and the behavior recovers at 48 h[4].
EEDQ (7.5 mg/kg; i.p.) does not disrupt NPA-induced stereotyped sniffing and locomotor activity in 11-day-old and 17-day-old Sprague-Dawley rat pups[5].

Your information is safe with us.